The leading independent clinical services provider

Interface employees work within a rigorous clinical and information governance framework designed to deliver the highest standards of care and safety and to comply fully with all legal and regulatory requirements. Our framework and working practices are fully aligned with NHS policies and procedures.

All Interface pharmacists must maintain registration with the relevant regulatory body and meet all required standards including confidentiality, continuing professional development and completing an annual Declaration of Fitness to Practice. This is monitored by the company.

All staff who access patient data have a Disclosure and Barring Service (DBS) or equivalent screening check upon commencement of employment and every three years subsequently. Any staff who have direct contact with patients have an enhanced screening check. All Interface employment contracts include a signed individual commitment to confidentiality.

Interface invests heavily in job-related learning and training and commissions external post-graduate accredited courses when they are needed to support the delivery of specific projects. Field visits undertaken by senior clinical staff provide assurance of the quality of service delivery and patient care.

Interface Clinical Services (Interface) is an NHS Business Partner and completes the Data Security and Protection Toolkit on an annual basis in the same way as all NHS organisations. Confirmation that the company has completed the toolkit can be found on the NHS Digital website. The company has designated a Senior Information Risk Owner, Caldicott Guardian and Data Protection Officer to ensure that information risk is managed robustly.

Personal data is managed in accordance with the NHS Code of Practice for Confidentiality and the National Data Guardian’s 10 data security standards.

Interface obtained Cyber Essentials Plus, a Government-backed scheme to help protect organisations against the most common cyber-attacks that is verified by independent experts, in September 2018.